Pathological complete remission in ALK-positive lung cancer patient after multiple lines of conversion therapy

INTRODUCTION: Traditional therapeutic approaches for the treatment of advanced non-small-cell lung cancer (NSCLC) are based on chemotherapy. However, the discovery and understanding of oncogenic driver alterations has led to the development of targeted therapies that have substantially improved pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Que, Dan, Zou, Hongbo, Mao, Bijing, Zhang, Huan, Liang, Wei, Liu, Qin, Ke, Leiyu, Guo, Lijie, Xie, Qichao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745108/
https://www.ncbi.nlm.nih.gov/pubmed/36523965
http://dx.doi.org/10.3389/fonc.2022.967675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745108/
https://www.ncbi.nlm.nih.gov/pubmed/36523965
http://dx.doi.org/10.3389/fonc.2022.967675

Ejemplares similares